Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Profit After Tax (2016 - 2025)

Aethlon Medical filings provide 15 years of Profit After Tax readings, the most recent being -$6.3 million for Q1 2025.

  • On a quarterly basis, Profit After Tax fell 157.89% to -$6.3 million in Q1 2025 year-over-year; TTM through Mar 2025 was -$13.4 million, a 9.66% decrease, with the full-year FY2025 number at -$13.4 million, down 9.66% from a year prior.
  • Profit After Tax hit -$6.3 million in Q1 2025 for Aethlon Medical, down from -$1.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$1.8 million in Q4 2024 to a low of -$6.3 million in Q1 2025.
  • Median Profit After Tax over the past 5 years was -$2.8 million (2024), compared with a mean of -$3.0 million.
  • Biggest five-year swings in Profit After Tax: surged 49.37% in 2024 and later tumbled 157.89% in 2025.
  • Aethlon Medical's Profit After Tax stood at -$2.5 million in 2021, then decreased by 12.83% to -$2.8 million in 2022, then fell by 21.63% to -$3.5 million in 2023, then soared by 49.37% to -$1.8 million in 2024, then tumbled by 256.45% to -$6.3 million in 2025.
  • The last three reported values for Profit After Tax were -$6.3 million (Q1 2025), -$1.8 million (Q4 2024), and -$2.8 million (Q3 2024) per Business Quant data.